Table 1 Treatment schedule for patients with locally recurrent NPC
Treatment schedule | No. (%) |
|---|---|
Chemotherapy | |
 Neo + RT | 77 (41.8) |
 Neo + CCRT | 23 (12.5) |
 Neo + RT + Adj | 17 (9.2) |
 CCRT | 10 (5.4) |
 CCRT+Adj | 4 (2.2) |
 Neo + CCRT+Adj | 2 (1.1) |
 RT + Adj | 5 (2.7) |
 IMRT alone | 46 (25) |
 Cetuximab | 9 (4.8) |
 Nimotuzumab | 10 (5.4) |
IMRT | |
IMRT dose (Gy) | |
 Median (range) | 66.7 (42–77) |
Fractional dose(Gy) | |
 1.8 | 1 (0.5) |
 2.0 | 125 (67.9) |
 2.1 | 44 (23.9) |
 2.2 | 6 (3.3) |
 2.3 | 7 (3.8) |
IMRT treatment duration (days) | |
 Median (range) | 46 (29–64) |
 Brachytherapy | 13 (7.1) |